Stanley Erck, Novavax CEO (Photographer: Kevin Dietsch/UPI/Bloomberg via Getty Images)

Covid-19 roundup: No­vavax set to re­lease its first vac­cine batch in US; Switzer­land to buy over 1200 dos­es of Evusheld

No­vavax, which re­ceived the FDA’s emer­gency use ap­proval for its Covid vac­cine last week, is all set to re­lease its first lot in the US soon, Reuters re­port­ed.

While the No­vavax vac­cine may soon be avail­able, the ques­tion re­mains how many Amer­i­cans will ac­tu­al­ly get the No­vavax jab, as the CDC es­ti­mates that over 80% of Amer­i­cans old­er than 5 have al­ready re­ceived at least one dose of a Covid-19 vac­cine.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.